BioCentury
ARTICLE | Clinical News

Lower dose submicron diclofenac regulatory update

March 11, 2013 7:00 AM UTC

Iroko said FDA accepted for review an NDA for lower dose submicron diclofenac to treat mild to moderate acute pain in adults. The company declined to disclose the PDUFA date or the date it submitted t...